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Abstract
Toxoplasma gondii, an obligate intracellular apicomplexan parasite, utilizes gliding
motility for active penetration and proactive egress from host cells. Gliding motility is made
possible in apicomplexan parasites by use of the myosin motor complex, which is an actinactivated molecular motor. Toxoplasma actin is encoded by the single copy ACT1 gene which is
transcribed and translated into a single actin isoform and is inherently unstable in the filamentous
form. In T. gondii, globular actin polymerizes to filamentous actin and is then driven rearward by
the myosin motor during gliding motility. Prior research has shown differences between
Apicomplexan and mammalian actin and myosin. The in vitro motility assay is used to study the
Toxoplasma myosin motor complex, and chicken skeletal muscle actin is used in place of
Toxoplasma actin. Here, recombinant Toxoplasma actin is expressed, purified, and polymerized
in preparation for labeling and use in the in vitro motility assay. Confirmation of Toxoplasma
actin expression was achieved by sequencing baculovirus encoding recombinant Toxoplasma
actin and western blot analysis. Purification was achieved via nickel affinity chromatography,
followed by cycles of polymerization and depolymerization. Preparing stabilized and labeled
actin filaments allows for the comparison of the speeds Toxoplasma myosin moves Toxoplasma
actin versus mammalian actin.
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Author Summary
The Apicomplexa phylum, which includes Toxoplasma gondii, is responsible for a
number of diseases (including toxoplasmosis, malaria, and cryptosporidiosis) and deaths
worldwide. T. gondii requires the ability to invade and exit cells of the host to remain infectious
as well as to replicate. This is all achieved by parasite motility – dependent on a complex of
proteins, including actin and myosin, which are relatively well conserved within the
Apicomplexa phylum. However, Apicomplexan actins differ in a number of key respects from
mammalian actins. The motility assay utilized to study the parasite motor complex currently uses
chicken skeletal muscle actin in place of Toxoplasma actin. We work here to express, purify, and
stabilize Toxoplasma actin for use in the motility assay currently used to study the T. gondii
motility complex, to enable a preliminary comparison of the interaction of chicken skeletal
muscle actin versus Toxoplasma actin with recombinant Toxoplasma myosin motor complex.
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Introduction
Toxoplasma gondii is capable of infecting nucleated cells of warm-blooded vertebrates,
causing toxoplasmosis. Infections are typically caused by ingestion of contaminated food or
water (1). T. gondii, an obligate intracellular apicomplexan parasite, utilizes gliding motility for
active penetration and proactive egress from host tissues and cells (2-4). The study of
Apicomplexan motility is important because motility is required to cause morbidity and mortality
in hosts. Gliding motility is made possible in apicomplexan parasites by use of the myosin motor
complex (Figure 1), which is an actin-activated molecular motor, situated within the cortical
domain of the parasite. Rearward translocation of actin-associated cell surface adhesins is driven
by the myosin motor complex anchored to an internal membrane complex, causing forward
movement of the parasite (5, 6).
Apicomplexan myosin is composed of three domains: the force generating and actinbinding motor domain, the neck domain, and the C-terminal tail domain, which coordinates the
light chains utilized in parasite motility (7). Myosin utilizes chemical energy from ATP
hydrolysis to create mechanical energy. Motility in T. gondii involves Myosin A (TgMyoA),
which is associated with two light chains, Myosin Light Chain 1 (TgMLC1) and Essential Light
Chain 1 (TgELC1). When both TgMLC1 and TgELC1 are bound to the TgMyoA motor, the
speed of actin movement is close to that of the motor complex isolated from parasites (8). To
express a functional TgMyoA motor, a T. gondii myosin co-chaperone is required for proper
folding of the TgMyoA heavy chain. This finding allowed for high yield expression of the
TgMyoA motor complex and has allowed further detailed study of the Toxoplasma motor
complex (8). It has also been shown that the TgMyoA heavy chain is one of 11 myosin heavy
chains found in T. gondii and is a part of the TgMyoA motor located between the inner
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membrane complex and plasma membrane in parasites (9). TgMyoA is distinguished from other
myosin motors due to the presence of Gln, rather than an acidic residue or a phosphorylatable
residue in a key actin binding surface loop that is otherwise highly conserved (10, 11).
Toxoplasma actin is encoded by the single copy ACT1 gene which is transcribed and
translated into a single actin isoform (5, 12). Toxoplasma actin, not host cell actin, has been
shown to be essential for survival with gliding motility and host cell invasion both being
compromised by lack of actin. Parasite egress is also not observed in the absence of parasite
actin (4, 13, 14). Parasite actin is found primarily in the globular form (G-actin), and when
filaments polymerize for motility, they are short and intrinsically unstable (15, 16). Filamentous
actin (F-actin) consists of a right-handed helical spiral of two interwoven parallel strands formed
by a self-polymerized head-to-tail dimer (17). The failure to generate cross-strand interactions
that provide strong annealing may lead to the inherent instability of T. gondii ACT1 (TgACT1)
(18). The abundance of F-actin has been shown to be rate limiting for motility, as the
polymerization of actin filaments coordinates the initiation and directionality of movement (19).
In most eukaryotic cells, the sequence of actin is highly conserved, however
apicomplexans encode more divergent actins. TgACT1 shows an 83% amino acid identity with
mammalian muscle actin, and a 93.1% identity with Plasmodium falciparum actin (Figure 2a)
(12, 15). Some amino acid differences can be seen at residues found to interact with the actin
binding domain of myosin (Figure 2b, green boxes) (20). Additional amino acids interacting with
the binding domain of myosin have also been identified (Figure 2b, orange boxes) (21).
Apicomplexan parasite actins share divergent sequence features at the monomer surface with
actins of close relatives, such as ciliates. These features have the potential to affect proteinprotein interactions with actin-binding proteins or within the filaments. One such difference in T.
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gondii is Arg277 (Figure 2b, red box), which is implicated in intermonomer salt bridge and
hydrogen bond interactions. In TgACT1, this salt bridge is likely weakened due to an
unfavorable Arg-Arg pairing (18). Another alteration in apicomplexan actins is seen within the
hydrophobic plug. In T. gondii, according to the Holmes model, there would likely be additional
destabilization between subunits across the filaments due to the alteration in the hydrophobic
plug (Figure 2b, pink boxes). Experiments in which Gly200 and Lys270 in Toxoplasma actin
have been substituted to the mammalian actin residue have shown Toxoplasma actin filaments
that formed significantly longer filaments than the wild type Toxoplasma actin filaments (15,
18). The actin-binding proteins found within apicomplexans include actin depolymerizing factor,
cyclase associated protein, profilin, and capping protein (22, 23).
Recombinant Toxoplasma actin (rTgACT1), produced in the baculovirus expression
system, can be stabilized by the addition of equimolar levels of phalloidin to form long stable
filaments that resemble conventional actin (15). Mapping of the phalloidin-binding domain in
Plasmodium falciparum and T. gondii has shown six specific differences in residues contacting
phalloidin in TgACT1 and PfACTII (actin in P. falciparum) versus mammalian muscle actin.
These differences may cause the decreased binding efficiency of phalloidin to parasite actin
filaments (15). Stabilization of Toxoplasma actin can also be achieved by the reversion of two
key residues in Toxoplasma actin to match those of mammalian muscle actin (15). When
expressed in parasites, these substitutions in TgACT1 modestly affected parasite cell division
over the first 24-36 hours, and detrimentally affected gliding motility, which is supportive of
conclusions drawn from Jasplakinolide (JAS) stabilization of actin (see below). Parasites
expressing the stabilized actin moved more slowly, in circles with larger radii, and stalled while
engaging in gliding motility (15).
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JAS, a cyclopeptide, is useful for examining actin dynamics in live cells, as it is a
membrane-permeable probe. JAS induces actin polymerization by binding to and stabilizing
filaments, releasing monomeric actin from sequestering proteins, and decreasing the critical
number of subunits necessary to induce polymerization (24, 25). When recombinant TgACT1
was treated with JAS for artificial stabilization, well defined TgACT1 filaments, with typical
striations and slight helical twists, were formed in vitro. This led to cross linking between
filaments, and an increase in overall length of filaments in vitro. However, JAS-treated TgACT1
filaments were still shorter than rabbit actin filaments (18). In parasites, JAS-treatment induced
actin filament polymerization at specific sites rather than randomly, and increased TgACT1
lengths of filaments (18, 26). In addition, video microscopy of JAS-treated parasites showed they
moved faster but with frequent direction reversals disrupting directed gliding (19).
The Toxoplasma motor complex has been assayed in in vitro motility assays to study
TgMyoA function and demonstrated that actin moved at speeds similar to speeds of parasite
motility on two dimensional surfaces and in three dimensional Matrigel (2, 27). The actin used in
these in vitro motility assays however was rhodamine-phalloidin labeled chicken skeletal muscle
actin, not actin from the parasite (8). A recent study demonstrated that P. falciparum MyoA
moved Plasmodium actin filaments stabilized with JAS at the same speed as skeletal muscle
actin (28).
As outlined above, prior research on the apicomplexan gliding motility motor complex
has shown differences in actin, specifically TgACT1 is considerably divergent from mammalian
actins which are typically highly conserved. Prior research has also demonstrated that human Factin from skeletal and cardiac muscle, which differ at only four side chains, show differences in
motility velocity with porcine β-myosin (29). It is unknown whether the Toxoplasma motor
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complex will interact with and move Toxoplasma actin differently from chicken skeletal muscle
actin in in vitro motility assays. While one study (28) has done some initial research with the
Plasmodium motor complex and its ability to translocate Plasmodium versus skeletal muscle
actin, further research is necessary.
With prior research demonstrating that there is the possibility for differences in motility
and the way different F-actins interact with a given myosin, alongside the differences of
Toxoplasma actin and myosin compared to mammalian actins and myosins, further study of
TgMyoA function with the actin T. gondii utilizes for active penetration, proactive egress, and
motility is necessary to determine whether there is a functional difference between Toxoplasma
and chicken skeletal muscle actin in motility assays. In this study, we work to purify Toxoplasma
actin from recombinant baculovirus encoding Toxoplasma actin, that has been polymerized and
depolymerized, for use in the in vitro motility assay.
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Figure 1. Schematic of T. gondii myosin motor complex. Previously published schematic of T. gondii
myosin motor complex components (8). In the myosin motor complex, myosin associated with the inner
membrane complex binds to actin associated with the parasite plasma membrane, and the actin is driven
rearward. This rearward actin movement drive the parasite forward.
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Figure 2. Actin Sequence Alignments. (a) Comparative amino acid identity percentage graphed based on
(b) sequence alignment of Chicken skeletal muscle actin, Toxoplasma actin, and Plasmodium actin.
Aligned using Clustal Omega multiple sequence aligner (30). Amino acids affecting actin filament stability
highlighted in red (18) and purple (15). Amino acids interacting with the myosin actin binding domain
highlighted in green (20) and orange (21).
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Results
Successful expression of recombinant Toxoplasma actin in insect cells (Figure 3a), as
well as confirming the baculovirus-encoded actin was both free of mutations (Figure 3b) and
inserted in the vector as described (Figure 3c) (18), demonstrated the recombinant baculovirus
and Sf9 insect cell system was an effective model for the expression of recombinant Toxoplasma
actin.
Purification of Toxoplasma actin was achieved via nickel charged affinity
chromatography (Figure 4a). Identification of the purified band as actin was confirmed by
western blotting with an anti-actin antibody (Figure 4b). The His6 tag was removed with
thrombin to avoid any possible secondary effects on polymerization, depolymerization or any
motility assay proteins. The slight decrease in molecular weight (to ~42kD) after His6 removal is
evident on the western blot (Figure 4b). To ensure that actin being fluorescently labeled for use
in the in vitro motility assay was functional, the purified protein was taken through one cycle of
polymerization/depolymerization (Figure 4c). From each 200 mL infection, approximately 2.9
mg of actin were recovered following nickel affinity purification, as determined by comparison
of the actin band intensity to that of known amounts of low molecular weight standards on an
Aqua Stained SDS gel (data not shown). With each step following affinity chromatography, 2575% of the actin was lost.
TRITC-phalloidin binds to polymerized actin at the cleft between two monomers (31).
Polymerized Toxoplasma actin bound by phalloidin was visualized (Figure 5a), however long
filaments such as those formed by vertebrate actin were not formed (Figure 5b). Potential
reasons for this are presented in the Discussion.
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Figure 3. Verification of TgACT1 expression in Baculovirus system. (a) TgACT1 expression
by Sf9 cells infected with baculovirus encoding recombinant TgACT1 was verified via 10% SDSPAGE and western blot of insect cell extracts probed with rabbit anti-actin primary antibody.
Different dilutions of the solubilized insect cell pellet (sonicated for either 30- or 60-minutes) were
loaded, as indicated. RH strain parasites were loaded to provide an actin positive control (box). (b)
Primer location and sequencing of recombinant TgACT1 in the baculovirus vector. Reference
sequence (black bar) was constructed electronically via insertion of RH strain T. gondii cDNA
sequence into pAcHLT-C vector backbone using NdeI and EcorI restriction enzymes. Purple text
above reference sequence highlights primers used for sequencing. Green arrows indicate primers
used, direction, and length of sequencing results. (c) Vector map of recombinant pAcHLT-C
TgACT1 from the Sibley Lab (18), electronically constructed via insertion of RH strain T. gondii
cDNA sequence into pAcHLT-C vector backbone using NdeI and EcorI restriction enzymes.
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Figure 4. Purification and labeling of TgACT1. (a) His6-TgACT1 (arrowhead) purified via
nickel charged affinity resin was resolved on a 10% SDS-PAGE gel and visualized via Aqua Stain
Protein Gel Stain. (b)Verification of TgACT1 presence after cleavage of His6 from purified
TgACT1. Samples were resolved via 10% SDS-PAGE and western blot probed with rabbit antiactin primary antibody. (c) TgACT1 (arrow) was incubated with F-Actin Buffer salts
(polymerization conditions) and then dialyzed against G-Actin Buffer (depolymerization
conditions) and separated after each treatment into pellet (p) and supernatant (s) fractions by
centrifugation at 300000xg. Samples resolved on a 10% SDS-PAGE gel and visualized via Aqua
Stain Protein Gel Stain. Additional band (star) is an unknown contaminating protein that appears
after thrombin cleavage.
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Figure 5. Visualization of polymerized actin. (a) TgACT1 stabilization and labeling was attempted with
TRITC phalloidin; the phalloidin-treated samples were imaged by fluorescence imaging on a Nikon
inverted epifluorescence microscope using NIS elements software. (b) Filamentous chicken skeletal muscle
actin prepared by the Warshaw lab was imaged by epifluorescence imaging.
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Discussion
Actin is a well-known protein with an important role in the motility of Toxoplasma
gondii and other apicomplexan parasites. In addition, actin is utilized in motility assays studying
many other aspects of the actin-myosin motor (8). We show here that it is possible to express
stabilized recombinant Toxoplasma actin that has been through a cycle of polymerization and
depolymerization.
The baculovirus expression vector system is widely utilized for recombinant protein
production in insect cells due to the large quantities of protein it is able to produce (32).
Expression of recombinant Toxoplasma actin still required several troubleshooting steps. First, it
was necessary to ensure that the baculovirus expression system was producing recombinant actin
and that no mutations were present in the actin sequence. This was accomplished by western blot
and sequence analysis of TgACT1. Second, due to the viscosity of the insect cell pellet after
infection with recombinant baculovirus and solubilization in sample buffer, the sample was
unable to be run on the protein gel. To run the protein on the protein gel, and conduct western
blot analysis, the cell pellet was water bath sonicated, and heavily diluted, producing clear results
that confirmed the presence of Toxoplasma actin.
Successful purification of TgACT1 required additional troubleshooting. Previously
published methods (15) to express and purify Toxoplasma actin merged with the manufacturer’s
protocol did not yield purified Toxoplasma actin. Rather it yielded a product with high amounts
of contaminating protein that eluted earlier than expected off the column. To troubleshoot the
purification wash and elution buffer volume, the protein was washed in greater volumes of wash
buffers. However, it was determined that lower amount of imidazole in the wash buffers were
necessary to remove contaminating proteins from the nickel affinity resin. An imidazole elution
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gradient was conducted to determine the concentration at which, subjectively, the largest amount
of contaminating protein was washed off the column, while losing the least amount of actin.
Using data from these troubleshooting steps, Toxoplasma actin was purified from the nickel
affinity column.
Polymerization kinetics and ion requirements of Toxoplasma actin and Plasmodium actin
have been published previously; however, the findings vary between studies. It has been reported
that the critical concentration of Toxoplasma actin, the concentration at which actin
polymerization begins, was ~0.04µM (18). A later publication from the same group (33) reports,
that upon reexamination, Toxoplasma actin polymerization is isodesmic, and therefore does not
have a critical concentration. The previous findings are briefly addressed by stating the
isodesmic conclusion is based off a larger range of actin polymerization concentrations while the
previous publication only reported at low actin concentrations. Contrasting both results is a
publication (34) which reports that the critical concentration of Plasmodium actin is ~4µM.
These three reports describing the kinetics of apicomplexan actin filament formation highlight
one of the difficulties in studying Toxoplasma actin, that there is no consensus on the dynamics
of polymerization. In addition, the intrinsic instability of Toxoplasma actin has led to varied g
forces used to sediment polymerized actin, with different groups achieving success at different g
forces. Through many rounds of centrifuge speed trouble shooting, we were able to sediment
polymerized actin (at 300000xg) and depolymerize previously sedimented actin, with the
depolymerized actin remaining in the supernatant. The need to polymerize and depolymerize
actin, prior to a final polymerization and stabilization step is supported by the intrinsic instability
of Toxoplasma actin. Actin is a dynamic protein in the parasite, with actin remaining in
filamentous form for extremely brief periods of time. Therefore, to best mimic parasite
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conditions in the in vitro motility assay, the actin used needs to undergo similar dynamics prior
to use in experimentation.
When stabilization and labeling of the polymerized actin was attempted with TRITC
phalloidin, formation and/or stabilization of filaments did not occur. Previous research has
shown at low actin concentrations, where phalloidin stabilization did not occur, Toxoplasma
actin that had polymerized formed small clumps rather than filaments (33). The lack of
stabilization into filaments may have been due to the length of time during which stabilization
was attempted, or the concentration of phalloidin utilized. Further troubleshooting of
polymerized Toxoplasma actin stabilization will be necessary prior to use in in vitro motility.
The in vitro motility assay is utilized frequently to study myosin function, small molecule
inhibitors of myosin, and additional proteins associated with the myosin motor complex.
Understanding whether the in vitro motility assay is capturing what is occurring in the parasite is
important. In in vitro motility assays, if Toxoplasma myosin is shown to move Toxoplasma actin
as the same speed as chicken skeletal muscle actin, the continued use of chicken skeletal muscle
actin can be supported. However, if Toxoplasma actin moves at different speeds, it will be
necessary to repeat previous experiments that have utilized the in vitro motility assay to elucidate
whether differences in TgMyoAs interaction with Toxoplasma actin affect previously drawn
conclusions. Additionally, utilization of the ATPase activity assay, to determine if the rate of
ATP hydrolysis by Toxoplasma myosin varies in the presence of the different actins will further
demonstrate if the continued use of chicken skeletal muscle actin can be supported when
studying T. gondii’s motor complex. The continued research of the myosin motor complex as a
target for pharmacological agents, as well as its importance for parasite motility justify the
continued research of the associated proteins in the motor complex.
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Materials and Methods
Cell Culture
Sf9 insect cells (Gibco Cell Culture, Gaithersburg, MD) were maintained in Serum Free Medium
Complete (Gibco Cell Culture) containing 5% (v/v) heat inactivated fetal bovine serum (FBS),
1% (v/v) Penicillin/Streptomycin (10000U/mL / 10000ug/mL), and 0.05% (v/v) 50mg/mL
Gentamicin Reagent Solution (Gibco Cell Culture) at 27oC.
Protein Staining and Western Blotting
Protein samples were boiled in SDS-PAGE sample buffer at 1X final concentration in the
presence of β-mercaptoethanol for five minutes. Protein samples were resolved on a 10% SDSPAGE gel and visualized by staining with Aqua Stain Protein Gel Stain (Bulldog Bio,
Portsmouth, NH) or transferred to PVDF for western blot analysis. For western blots, membranes
were blocked overnight at 4oC with Odyssey Blocking Buffer (LI-COR, Lincoln, NE) diluted 1:1
with TBS overnight at 4oC. Membranes were incubated for one hour with rabbit anti-actin
primary antibody (Sibley Lab, St. Louis, MO) diluted 1:1000. Membranes were then washed
three times for 15 minutes with TBST (0.15M NaCl, 0.02M Tris, pH 7.4, 1% v/v Tween-20) and
incubated for one hour, in the dark, with goat-anti-rabbit secondary antibody (LI-COR) diluted
1:20000. Membranes were again washed three times for 15 minutes with TBST. Gel stains and
western blots were imaged on LI-COR Odyssey CLx.
Toxoplasma Actin Expression and Sequence Verification
Recombinant TgACT1 was amplified by harvesting Sf9 cells infected with recombinant
baculovirus containing TgACT1 (18) 7 days post infection. Infected Sf9 cells were then
centrifuged (IEC Centra MP4R) at 800xg for 10 minutes. The pellet was resuspended in 1X
SDS-PAGE sample buffer, boiled, water bath sonicated for 30 or 60 minutes, and resolved on a
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10% SDS-PAGE gel followed by western blot.
Virus was recovered from the Sf9 infection supernatant by centrifugation at 20000xg for 15
minutes at 4oC in an ultracentrifuge (Optima TLX ultracentrifuge, Beckman TLA 100.3 rotor).
The pellet was then resuspended in disruption buffer (1M Tris, pH 7.5, 0.1M EDTA, 10% SDS,
proteinase K) and incubated overnight at 37oC in a water bath. Overnight solution was
neutralized with neutralization solution and mini prepped (Promega, Madison, WI). gDNA was
amplified by polymerase chain reaction with Phusion HF DNA Polymerase (New England
Biolabs, Ipswich, MA) and polyhedrin forward and reverse primers (Table 1) in a Techne Prime
Thermal Cycler (Staffordshire, UK). Amplified gDNA sequenced with TgACT1 R 157, TgACT1
R EcorI, TgACT1 F NdeI, TgACT1 F 549. and TgACT1 F 1071 primers (Table 1 & Figure 1b).
Primer Name
Polyhedrin Forward
Polyhedrin Reverse
TgACT1 R 157
TgACT1 R EcorI
TgACT1 F NdeI
TgACT1 F 549
TgACT1 F 1071

Sequence
5’-TTTACTGTTTTCGTAACAGTTTTG-3’
5’-CAACAACGCACAGAATCTAG-3’
5’-GCTTCGTCACCGACGTAGC-3’
5’-GAATTCTTAGAAGCACTTGCGGTG-3’
5’-GCATATGTATGGCGGATGAAGAAGT-3’
5’-ACGCGACCTTACCGAGTAC-3’
5’-ATCACCAAGGAGGAGTACG-3’

Table 1. Amplification and sequencing primers.

Toxoplasma Actin Expression and Purification
To express His6-TgACT1 for Histidine affinity purification on a nickel affinity resin, 1*109 Sf9
cells in 200mLs were infected with 3.25mLs 4X recombinant baculovirus containing TgACT1
for 48 hours. The cells were harvested and pelleted, at ~85% viability post infection, by
centrifugation (RC5B Centrifuge, Sorvall GSA rotor) at 4000xg for 10 minutes at 4oC.
The cell pellet was resuspended in G-Actin Buffer (5mM Tris-Cl, pH 7.5, 0.2mM CaCl2, 0.2mM
ATP) containing 2% Triton X-100 and Protease inhibitor cocktail (Sigma p8340) and sonicated
(Fisher Scientific, Waltham, MA) on ice at 20% amplitude for 5 seconds pulse on, 10 seconds
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pulse off, for 4 cycles. Cell lysate was centrifuged at 3000xg (Sorvall SA600 rotor) for 15
minutes at 4oC. The post spin supernatant was transferred to Ni-NTA column (Invitrogen,
Carlsbad, CA) and batch adsorbed for one hour at 4oC. The Ni-NTA column was washed with
Native Wash Buffer (20mM NaPO4, 500mM NaCl, pH 5.5, 0.5% Triton X-100), Native Wash
Buffer with 0.5M KCl, Native Wash Buffer with 10mM Imidazole and Native Wash Buffer with
30mM Imidazole. His6-TgACT1 was eluted with G-Actin Buffer containing 100mM Imidazole,
followed by G-Actin Buffer containing 1M Imidazole.
His6 Cleavage and TgACT1 Polymerization
His6-TgACT1 eluted in G-Actin Buffer containing imidazole was dialyzed overnight at 4oC
against G-Actin Buffer, and then incubated for 90 minutes with 1U of Thrombin per 10µg His6TgACT1 at room temperature. The actin was then transferred to the Ni-NTA column, batch
adsorbed for one hour at 4oC, and the flow through containing TgACT1 collected.
F-Actin Buffer salts (100mM KCl, 2mM MgCl2, 2mM ATP) were added to the flow through,
incubated for 1 hour at room temperature followed by an overnight incubation at 4oC and
centrifuged (Sorvall T885 rotor) at 300000xg in an ultracentrifuge (Sorvall Discovery 90
ultracentrifuge) at 4oC. The pellet was resuspended in F-Actin Buffer, dialyzed overnight at 4oC
in G-Actin Buffer, and centrifuged at 300000xg at 4oC. F-Actin Buffer salts were again added to
the supernatant and incubated for 1 hour at room temperature followed by an overnight
incubation at 4oC. The overnight sample was incubated for 1 hour in the dark with TRITC
phalloidin (Sigma-Aldrich, St. Louis, MO) at an equimolar concentration with the actin, and
centrifuged at 200000xg at 4oC. Pelleted actin was resuspended in F-Actin Buffer.
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Protein Quantification
Protein samples and low molecular weight standards (GE Healthcare, Buckinghamshire, UK)
were run on Mini-PROTEAN TGX Stain-Free Gels (BIO-RAD, Hercules, CA), and visualized
by staining with Aqua Stain Protein Gel Stain. Gel staining was imaged on LI-COR Odyssey
CLx and analyzed with Image Studio Software.
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